Julius Baer is set to launch its actively-managed global convertible bond fund into the UK retail sp...
Hargreaves Lansdown has pulled a raft of funds from its Wealth 150 list, citing poor manager perform...
The FTSE 100 has fallen more than about 1% this morning despite better-than-excepted results from Ba...
Biotech companies are in need of greater backing from investors as generic drugmakers move in on expiring patents to produce cheaper versions
10-manager team reduces market exposure to lowest level ever as a result of bearish stance on short-term growth
Volatility in financial stocks saw Cazenove UK Equity Absolute Return fund lose 1% of performance bu...
Corporate refinancing will give small and mid-cap fund managers a wall of equity to buy in 2009, acc...
By next month the darling of the fund management industry in the 1980s - Henderson, and the darling ...
Michael Clark's latest Fidelity offering aims to mirror his existing Income Plus vehicle
Specialist sector fragmented as component fund performances differ greatly, with gold and US dollar particularly hit by indiscriminate asset selling